Study title: A twelve week double blind multicentre comparaison of sertraline and placebo in patients with obsessive-compulsive disorder. (Strength: 50mg; Pharmaceutical form: capsules)
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Behavior and Behavior Mechanisms [F01] | |||||
| Brands: | |||||
| MAH holders: Please see report, Please see report | |||||
| Assessment: | |||||
| Active substance: SERTRALINE | |||||
| ATC code: N06AB06 | |||||
| Document link: | |||||
| Document date: | |||||
| Study number: 336 | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | - | - | |